Stem Cell :: State seeds stem cell company based on UW-Madison research
Governor Jim Doyle gave a $1 million boost to a University of Wisconsin-Madison spin-off company during a visit to the campus lab that gave birth to its technology.
Company
Vaccine :: Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine
A thin strip that dissolves in the mouth like a popular breath-freshener could someday provide life-saving rotavirus vaccine to infants in impoverished areas. The innovative drug-delivery system was developed by Johns Hopkins undergraduate biomedical engineering students.
Cancer :: Teva Announces Tentative Approval of Generic Gemzar for Injection
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eli Lilly and Co’s cancer treatment Gemzar? (Gemcitabine) for injection, 200 mg base/vial.
Antibiotic :: Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Applications (ANDA) to market its generic versions of Abbott’s antibiotic Omnicef? (Cefdinir) Capsules, 300 mg, and for Oral Suspension, 125 mg/5 mL and 250 mg/5 mL. Teva has commenced shipment of these products.
GERD :: Teva Provides Update on Generic Aciphex Litigation
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA)announced that the U.S. District Court for the Southern istrict of New York has issued a decision in its litigation over the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eisai’s acid pump inhibitor Aciphex? (Rabeprazole Sodium) Tablets, 20 mg.
Gastric Ulcer :: Axcan announces the U.S. Launch of PYLERA, Therapy for the Eradication of Helicobacter Pylori
Axcan Pharma Inc. (TSX:AXP)(NASDAQ:AXCA) announced the launch of PYLERA in the United States. PYLERA is a patented 3-in-1 capsule triple therapy for the eradication of Helicobacter pylori, which is a bacterium recognized as being the main cause of gastric and duodenal ulcers.
Pain :: FDA announces results of investigation into illegal promotion of OxyContin by The Purdue Frederick Company
The U.S. Food and Drug Administration’s (FDA) Office of Criminal Investigations (OCI) announced that The Purdue Frederick Company, Inc. has agreed to pay more than $600 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin, a powerful prescription pain reliever that the company produces.
Breast Cancer :: Halo Breast Pap Test for breast cancer
A new test may be able to identify women at risk for breast cancer long before a lump appears on a mammogram, according to the makers of the new test, called Halo? Breast Pap Test System.
Osteosarcoma :: FDA reviews IDM Pharma’s Junovan for treatment of osteosarcoma
IDM Pharma, Inc. (NASDAQ: IDMI) announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to 2 that the results of INT 0133, the Phase 3 trial, do not provide substantial evidence of effectiveness of Junovan (mifamurtide) in the treatment of patients with non-metastatic, resectable osteosarcoma receiving combination chemotherapy.
E Coli :: E Coli, food borne illness linked to ground beef consumption
Dr. Eric E. Whitaker, state public health director, issued a warning about E. coli O157:H7, a specific strain of E. coli, associated with the consumption of some beef trim meat used to make ground beef. The U.S. Department of Agriculture?s Food Safety and Inspection Service announced that a Minnesota company has recalled 117,500 pounds of beef trim products due to possible contamination.